LOS), re-intervention, and readmission rates. Multivariable logistic regression models assessed the independent effect of MI on postoperative outcomes.RESULTS: 5338 patients were identified: 2261 (42.4%) underwent MI myomectomy and 3074 (57.6%) underwent abdominal myomectomy. The mean age of the patients in the MI group and abdominal myomectomy group were 38.4 (SD¼7.3) years and 37.4 (SD¼6.4) years (p<0.001), respectively. There were small, yet significant, differences in the composition of race, body mass index, smoking and diabetic status between the two groups. The mean operative time in the MI group was 170.9 minutes and 132.2 minutes in the abdominal group, (p< 0.001). The mean LOS was 0.72 days (SD¼2.9) in the MI group and 2.27 days (SD¼1.9) in the abdominal group. In adjusted-analyses (Table 1), open myomectomy had increased odds for (OR¼2.16; 95% CI: 1.49-3.13) for complications (any). Specifically, open myomectomy was associated with increased odds for wound infections (OR¼1.70; 95% CI: 1.02-2.84) and urinary tract infections (OR¼2.52; 95% CI: 1.34-4.72). Odds for transfusion were also significantly reduced (OR¼2.89; 95% CI: 2.24-3.71). Odds for readmission were greater in the abdominal group as well (OR¼1.82; 95% CI: 1.09-3.04). There was no significant difference in the odds for developing DVT between MI and abdominal myomectomy.CONCLUSIONS: Patients who underwent abdominal myomectomy had overall increased odds for complications, longer LOS, and readmission but only minimally shorter operating times than MI myomectomy. These findings may mitigate the operative costs of minimally invasive myomectomy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.